4.06 USD
0 (0%)
4.08 USD
+0.02 (+0.49%)
Overall THRX gets a fundamental rating of 3 out of 10. We evaluated THRX against 191 industry peers in the Pharmaceuticals industry. THRX has a great financial health rating, but its profitability evaluates not so good. THRX is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- THRX had negative earnings in the past year.
- In the past year THRX has reported a negative cash flow from operations.
1.2 Ratios
- THRX has a Return On Assets of -24.13%. This is in the better half of the industry: THRX outperforms 60.70% of its industry peers.
- THRX has a better Return On Equity (-25.22%) than 70.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -24.13% | ||
| ROE | -25.22% | ||
| ROIC | N/A |
ROA(3y)-57.73%
ROA(5y)N/A
ROE(3y)-68.96%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- THRX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- The number of shares outstanding for THRX remains at a similar level compared to 1 year ago.
- There is no outstanding debt for THRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 9.94 indicates that THRX is not in any danger for bankruptcy at the moment.
- THRX has a better Altman-Z score (9.94) than 85.57% of its industry peers.
- THRX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 9.94 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- A Current Ratio of 29.94 indicates that THRX has no problem at all paying its short term obligations.
- THRX has a Current ratio of 29.94. This is amongst the best in the industry. THRX outperforms 97.51% of its industry peers.
- A Quick Ratio of 29.94 indicates that THRX has no problem at all paying its short term obligations.
- With an excellent Quick ratio value of 29.94, THRX belongs to the best of the industry, outperforming 98.01% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 29.94 | ||
| Quick Ratio | 29.94 |
3. Growth
3.1 Past
- THRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.61%.
EPS 1Y (TTM)-12.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.42%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, THRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.83% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-0.43%
EPS Next 2Y12.36%
EPS Next 3Y13%
EPS Next 5Y16.83%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- THRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year THRX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- THRX's earnings are expected to grow with 13.00% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.36%
EPS Next 3Y13%
5. Dividend
5.1 Amount
- No dividends for THRX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
THESEUS PHARMACEUTICALS INC / THRX FAQ
What is the ChartMill fundamental rating of THESEUS PHARMACEUTICALS INC (THRX) stock?
ChartMill assigns a fundamental rating of 3 / 10 to THRX.
What is the valuation status for THRX stock?
ChartMill assigns a valuation rating of 0 / 10 to THESEUS PHARMACEUTICALS INC (THRX). This can be considered as Overvalued.
How profitable is THESEUS PHARMACEUTICALS INC (THRX) stock?
THESEUS PHARMACEUTICALS INC (THRX) has a profitability rating of 1 / 10.